{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:47:50Z","timestamp":1789055270403,"version":"build-2803163510"},"reference-count":24,"publisher":"Bioscientifica","issue":"1","content-domain":{"domain":["joe.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:p>Obesity is a serious health hazard with rapidly increasing prevalence in the United States. In 2014, the World Health Organization estimated that nearly 2 billion people worldwide were overweight with an estimated 600 million of these obese. Obesity is associated with many chronic diseases, including cardiovascular disease and hypertension. Data from the Framingham Heart study suggest that approximately 78% of the risk for hypertension in men and 65% in women is related to excess body weight, a relationship that is further supported by studies showing increases in blood pressure with weight gain and decreases with weight loss. However, the exact mechanism by which excess body fat induces hypertension remains poorly understood. Several clinical studies have demonstrated elevated plasma aldosterone levels in obese individuals, especially those with visceral adiposity, with decreased aldosterone levels measured in concert with reduced blood pressure following weight loss. Since aldosterone is a mineralocorticoid hormone that regulates blood volume and pressure, serum aldosterone levels may link obesity and hypertension. Nevertheless, the mechanism by which obesity induces aldosterone production is unclear. A recent study by Belin de Chantemele and coworkers suggests that one adipose-released factor, leptin, is a direct agonist for aldosterone secretion; other adipose-related factors may also contribute to elevated aldosterone levels in obesity, such as very low-density lipoprotein (VLDL), the levels of which are elevated in obesity and which also directly stimulates aldosterone biosynthesis. This focused review explores the possible roles of leptin and VLDL in modulating aldosterone secretion to underlie obesity-associated hypertension.<\/jats:p>","DOI":"10.1530\/joe-16-0160","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T23:50:44Z","timestamp":1464825044000},"page":"F7-F11","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":61,"title":["Obesity, hypertension and aldosterone: is leptin the link?"],"prefix":"10.1530","volume":"230","author":[{"given":"Ding","family":"Xie","sequence":"first","affiliation":[{"name":"1Department of Family MedicineMedical College of Georgia at Augusta University (formerly Georgia Regents University), Augusta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B","family":"Bollag","sequence":"additional","affiliation":[{"name":"2Charlie Norwood VA Medical CenterAugusta, Georgia, USA"},{"name":"3Department of PhysiologyMedical College of Georgia at Augusta University (formerly Georgia Regents University), Augusta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2016070718585413000_230.1.F7.1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-011-0182-2"},{"key":"2016070718585413000_230.1.F7.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2010.04.001"},{"key":"2016070718585413000_230.1.F7.3","unstructured":"Canale MP Manca di Villahermosa S Martino G Rovella V Noce A De Lorenzo A Di Daniele N 2013 Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. International Journal of Endocrinology 2013 865965. (doi:10.1155\/2013\/865965)"},{"key":"2016070718585413000_230.1.F7.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(01)00538-0"},{"key":"2016070718585413000_230.1.F7.5","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000259805.18468.8c"},{"key":"2016070718585413000_230.1.F7.6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2336140100"},{"key":"2016070718585413000_230.1.F7.7","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-978675"},{"key":"2016070718585413000_230.1.F7.8","doi-asserted-by":"publisher","DOI":"10.1016\/0091-7435(87)90087-9"},{"key":"2016070718585413000_230.1.F7.9","doi-asserted-by":"publisher","DOI":"10.1002\/j.1550-8528.1999.tb00418.x"},{"key":"2016070718585413000_230.1.F7.10","doi-asserted-by":"crossref","unstructured":"Huby AC Antonova G Groenendyk J Gomez-Sanchez CE Bollag WB Filosa JA & Belin de Chantemele EJ 2015 Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation 132 2134\u20132145. (doi:10.1161\/CIRCULATIONAHA.115.018226)","DOI":"10.1161\/CIRCULATIONAHA.115.018226"},{"key":"2016070718585413000_230.1.F7.11","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.06642"},{"key":"2016070718585413000_230.1.F7.12","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpw003"},{"key":"2016070718585413000_230.1.F7.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(97)00082-4"},{"key":"2016070718585413000_230.1.F7.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(03)00335-3"},{"key":"2016070718585413000_230.1.F7.15","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-12-3"},{"key":"2016070718585413000_230.1.F7.16","doi-asserted-by":"publisher","DOI":"10.1385\/ENDO:29:1:81"},{"key":"2016070718585413000_230.1.F7.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-012-1346-3"},{"key":"2016070718585413000_230.1.F7.18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1295459"},{"key":"2016070718585413000_230.1.F7.19","first-page":"169","article-title":"Circulating very-low-density lipoprotein from subjects with impaired glucose tolerance accelerates adrenocortical cortisol and aldosterone synthesis","volume":"45","author":"Saha","year":"2013","journal-title":"Hormone and Metabolic Research"},{"key":"2016070718585413000_230.1.F7.20","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-1514"},{"key":"2016070718585413000_230.1.F7.21","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1159"},{"key":"2016070718585413000_230.1.F7.22","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-014-0443-y"},{"key":"2016070718585413000_230.1.F7.23","doi-asserted-by":"publisher","DOI":"10.1210\/en.2010-1049"},{"key":"2016070718585413000_230.1.F7.24","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1752"}],"container-title":["Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/230\/1\/F7.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/230\/1\/F7.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:55:26Z","timestamp":1784555726000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/joe\/article\/230\/1\/F7-F11\/22846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":24,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1530\/joe-16-0160","relation":{},"ISSN":["0022-0795","1479-6805"],"issn-type":[{"value":"0022-0795","type":"print"},{"value":"1479-6805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}